Install
EurekAlert! is an online science news service featuring health, medicine, science and technology news from leading research institutions and universities. Sponsored by AAAS, the science society. Norwegian University of Science and Technology Graz University of Technology Michigan Medicine - University of Michigan Unive
- 1,292articles · 30d
- 2+ hour agolatest article
- Aug 14, 2026earliest in window
- 0%with images
- 221avg words
- Science & Nature 904
- Science & Technology 857
- STEM 558
- Health & Wellness 395
- Medical 310
- Health 192
- Environment 165
- Computers & Electronics 69
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Professor Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China. [IMAGE] | EurekAlert! Science News Releases
16+ hour, 56+ min ago (74+ words) dijo la profesora Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China. EurekAlert! Professor Jie Wang, National Cancer Center/National Clinical Research Center for Cancer…...
Professor Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China.
19+ hour, 14+ min ago (72+ words) EurekAlert! Professor Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China. More on this News Release Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves…...
Professor Li Zhang of Sun Yat-sen University Cancer Center, Guangzhou, China
15+ hour, 1+ min ago (43+ words) (IMAGE) EurekAlert! Professor Li Zhang of Sun Yat-sen University Cancer Center, Guangzhou, China More on this News Release Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer...
Chad Rusthoven, MD, of the University of Colorado School of Medicine [IMAGE] | EurekAlert! Science News Releases
17+ hour, 6+ min ago (46+ words) Chad Rusthoven, MD, of the University of Colorado School of Medicine (IMAGE) EurekAlert! Chad Rusthoven, MD, of the University of Colorado School of Medicine More on this News Release Phase III MAVERICK trial supports brain MRI surveillance alone as standard…...
Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
19+ hour, 42+ min ago (137+ words) B7-H3-directed antibody-drug conjugate reduced the risk of death by 54% compared with topotecan and improved progression-free survival and response rates At the June 6, 2026 data cutoff, after a median follow-up of 12.2 months, median overall survival was 18.5 months with Ris-Rez compared with 10.3 months…...
Prof. Caicun Zhou, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
17+ hour, 13+ min ago (47+ words) EurekAlert! Prof. Caicun Zhou, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. More on this News Release Late-breaking HARMONi-2 analysis shows ivonescimab significantly improves overall survival versus pembrolizumab in PD-L1-Positive Advanced NSCLC...
Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece [IMAGE] | EurekAlert! Science News Releases
15+ hour, 53+ min ago (43+ words) Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece (IMAGE) EurekAlert! Giannis Mountzios, M.D., of the Henry Dunant Hospital Center, Athens, Greece More on this News Release Sacituzumab govitecan plus pembrolizumab does not meet primary endpoints in first-line PD-L1-high…...
Protein linked to cell death may also drive liver cancer
3+ day, 22+ min ago (295+ words) Discovery could open new approach to liver cancer treatment image: University of Oklahoma College of Medicine researcher Deepa Sathyaseelan, Ph.D., is the senior author of a new study in Hepatology that sheds light on a protein linked to liver cancer....
Rare Coombs-negative hemolytic anemia reported following pembrolizumab treatment
3+ day, 22+ min ago (189+ words) image: Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: freeing oncology from publication costs. It is free to…...
First-in-human study at UCI Health attacks pancreatic cancer with laser light
3+ day, 22+ min ago (367+ words) Pancreatic cancer has one of the lowest survival rates of all cancers image: The clinical team injects the patient with the light-sensitive drug. Next, they insert a balloon into the tumor-encased blood vessel. Inside the balloon is a laser. When…...